• GlaxoSmithKline (GSK) Smacks Down $227 Million for Basilea Pharmaceutica (BSLN.SW) Skin Drug More...
• GlaxoSmithKline (GSK) Rumored to be Buying $5 Billion BioMarin Pharmaceutical Inc. (BMRN) More...
• Jazz Pharmaceuticals, Inc. (JAZZ) Completes EUSA Pharma Acquisition More...
• Shire plc (SHPGY)'s Advanced BioHealing, Inc. Plans Hundreds of New Jobs in San Diego Expansion More...
• Igenica, Inc. Closes $33 Million in Series C Funding More...
• Savara Raises $8.6 Million in Series B Financing Round More...
• Cobra Biologics Ltd. and Alligator Bioscience Sign Monoclonal Antibody Manufacturing Agreement More...
• Polyphor Signs MacroFinder® Collaboration With Boehringer Ingelheim Corporation More...
• BioInvent (BOVNF) and Cancer Research Technology Enter Oncology Collaboration More...
• Beijing Genomics Institute (BGI), GE Healthcare Team Up on Pioneering Stem Cell Science Projects More...
• Eli Lilly and Company (LLY) Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines More...
• Trophos Appoints Christine Placet as Chief Executive Officer More...
• ICON Announces Peter Gray to Retire from ICON Board of Directors More...
• BioScale, Inc. Appoints Proteomics Leader Martin Latterich as Chief Scientific Officer More...
• The Dow Chemical Company (DOW) Release: Geoffery Merszei to Retire After 30 Years of Service More...
• China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 More...
• Enzo Biochem (ENZ) Reports Fiscal Third Quarter Results More...
• Forest Laboratories, Inc. (FRX) Falls After Cutting Profit Outlook More...
• Supremes to Review Amgen (AMGN) Stock Fraud Case More...
• Protea Biosciences, Inc. Opens New Demonstration and Training Center More...
• UBICHEM Group Adds New Large Scale Manufacturing Site More...
• Suzhou Pharma Opens US Corporate Office More...
• SG Biofuels Opens Expanded Headquarters & Genomics Research Center to Support Commercial Advancements More...
• Vision Risks Linked to GlaxoSmithKline (GSK), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drugs More...
• Sanofi (France) (SAN.PA)'s Lantus Shows No Cancer, Heart Risks: Study More...
• Greer Labs Reports Positive Findings from Large Phase III Clinical Trial Evaluating Sublingual Immunotherapy for Ragweed Allergies More...
• Cytokinetics, Inc. (CYTK) Announces Publication of Phase II Evidence of Effect Study of CK-2017357 in the Journal Amyotrophic Lateral Sclerosis More...
• Nymox Pharmaceutical (NYMX) Announces First Patient Enrollment for Phase 2 Prostate Cancer Clinical Trial More...
• Sanofi (France) (SAN.PA) Submits Key MS Pill to FDA, European Medicines Agency for Approval More...
• Offspring of Older Fathers May Live Longer, Northwestern University Study More...
• Fish Oil Won't Save Diabetics' Hearts, McMaster University More...
• Low Levels of Brain Chemical May Boost Aggression, RWTH Aachen University Study More...
• Do Statins Drain Your Energy? University of California, San Diego (UCSD) Study More...
• Long Term Insulin Not Linked to Higher Risk of Heart Attack, Stroke, Cancer,McMaster University Study More...
• Amgen (AMGN)'s Xgeva Wins U.K. National Institute for Clinical Excellence (NICE) Backing for Some Cancer Patients More...
• PuraMed BioScience, Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver, CO Region to Coincide with the NACDS's Marketplace 2012 Trade Convention More...
• GlaxoSmithKline (GSK) Rumored to be Buying $5 Billion BioMarin Pharmaceutical Inc. (BMRN) More...
• Jazz Pharmaceuticals, Inc. (JAZZ) Completes EUSA Pharma Acquisition More...
• Shire plc (SHPGY)'s Advanced BioHealing, Inc. Plans Hundreds of New Jobs in San Diego Expansion More...
• Igenica, Inc. Closes $33 Million in Series C Funding More...
• Savara Raises $8.6 Million in Series B Financing Round More...
• Cobra Biologics Ltd. and Alligator Bioscience Sign Monoclonal Antibody Manufacturing Agreement More...
• Polyphor Signs MacroFinder® Collaboration With Boehringer Ingelheim Corporation More...
• BioInvent (BOVNF) and Cancer Research Technology Enter Oncology Collaboration More...
• Beijing Genomics Institute (BGI), GE Healthcare Team Up on Pioneering Stem Cell Science Projects More...
• Eli Lilly and Company (LLY) Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines More...
• Cytheris SA Appoints Damian Marron as Chief Executive Officer More...
• Trophos Appoints Christine Placet as Chief Executive Officer More...
• ICON Announces Peter Gray to Retire from ICON Board of Directors More...
• BioScale, Inc. Appoints Proteomics Leader Martin Latterich as Chief Scientific Officer More...
• The Dow Chemical Company (DOW) Release: Geoffery Merszei to Retire After 30 Years of Service More...
• China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 More...
• Enzo Biochem (ENZ) Reports Fiscal Third Quarter Results More...
• Forest Laboratories, Inc. (FRX) Falls After Cutting Profit Outlook More...
• Supremes to Review Amgen (AMGN) Stock Fraud Case More...
• Protea Biosciences, Inc. Opens New Demonstration and Training Center More...
• UBICHEM Group Adds New Large Scale Manufacturing Site More...
• Suzhou Pharma Opens US Corporate Office More...
• SG Biofuels Opens Expanded Headquarters & Genomics Research Center to Support Commercial Advancements More...
• Vision Risks Linked to GlaxoSmithKline (GSK), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drugs More...
• Sanofi (France) (SAN.PA)'s Lantus Shows No Cancer, Heart Risks: Study More...
• Greer Labs Reports Positive Findings from Large Phase III Clinical Trial Evaluating Sublingual Immunotherapy for Ragweed Allergies More...
• Cytokinetics, Inc. (CYTK) Announces Publication of Phase II Evidence of Effect Study of CK-2017357 in the Journal Amyotrophic Lateral Sclerosis More...
• Nymox Pharmaceutical (NYMX) Announces First Patient Enrollment for Phase 2 Prostate Cancer Clinical Trial More...
• Sanofi (France) (SAN.PA) Submits Key MS Pill to FDA, European Medicines Agency for Approval More...
• Offspring of Older Fathers May Live Longer, Northwestern University Study More...
• Fish Oil Won't Save Diabetics' Hearts, McMaster University More...
• Low Levels of Brain Chemical May Boost Aggression, RWTH Aachen University Study More...
• Do Statins Drain Your Energy? University of California, San Diego (UCSD) Study More...
• Long Term Insulin Not Linked to Higher Risk of Heart Attack, Stroke, Cancer,McMaster University Study More...
• Amgen (AMGN)'s Xgeva Wins U.K. National Institute for Clinical Excellence (NICE) Backing for Some Cancer Patients More...
• PuraMed BioScience, Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver, CO Region to Coincide with the NACDS's Marketplace 2012 Trade Convention More...
Lemon, a mobile money management startup, launch its new Smarter Wallet app that is designed to replace your physical wallet.
"A wallet that helps you spend smarter, that's a new twist"
The Smarter Wallet from Lemon does much more than store cards, receipts and coupons. It helps you access and use it in smart new ways. Think of it as your very own pocket-sized entourage that helps you track your spending, save money, and stay more secure.
The company says its "groundbreaking" app is designed to be incredibly easy to use, and indeed its main mechanical function couldn't be simpler: It captures an image of a physical thing in your wallet and digitizes it (recognizing characters and figures) so that you can throw receipts in the recycling bin and keep many of your loyalty, membership, and even credit cards safely at home. The app is secure with 32-bit encryption and allows you to remote-wipe the information contain within should you lose your phone
Cool things about app:
“Click, click, done.”
Getting started is as easy as snapping a photo of every credit card, debit card, loyalty card, and receipt in your wallet. Lemon extracts the important data and inserts a digital version in your Smarter Wallet. Add as many items as you choose, with no limits.
“Where’s that receipt/ticket/card?”
The Smarter Wallet acts like a personal assistant, helping you find exactly what you need when you need it: event tickets, dry-cleaning tickets, the loyalty card for your favorite café, the right credit card, or a receipt for a return. Everything is neatly labeled and easy to find.
“How can I spend smarter?”
The Smarter Wallet is also a money manager, showing you exactly how much money you have, how much you spend, and how to spend smarter. Tap a credit or debit card to see the balance. Tap a loyalty card to see your rewards balance. Tap again to see at-a-glance spending reports that show you where every dollar went each month. Plus, get exclusive, money-saving offers from your favorite retailers delivered directly to your smartphone.
“Lost Wallet?”
Security expert to the rescue! Unlike an ordinary wallet, the Smarter Wallet is theft-proof, because the contents are locked behind an unbreakable password. If your smartphone goes missing, your financial and personal information remain totally secure, and you can download the contents of your wallet to a new phone without missing a beat.
One hurdle for Lemon might come in the form of the PassBook app Apple just revealed is coming in iOS 6. It is similar enough to Lemon in a few ways. Again, however, Casares is not concerned. He was, in fact, pleased with the news as it "validates the ticketing and couponing compartments of Lemon's Smarter Wallet strategy."
As Lemon can scan credit cards, IDs, and reciepts, ultimately Apple may see this sort of app as a gateway app that gets consumers hooked on digital wallets, before it (possibly) sweeps in with its archive of over 400 million iTunes credit card details and launches a full payments solution of its own.
The Smarter Wallet from Lemon does much more than store cards, receipts and coupons. It helps you access and use it in smart new ways. Think of it as your very own pocket-sized entourage that helps you track your spending, save money, and stay more secure.
Cool things about app:
“Click, click, done.”
Getting started is as easy as snapping a photo of every credit card, debit card, loyalty card, and receipt in your wallet. Lemon extracts the important data and inserts a digital version in your Smarter Wallet. Add as many items as you choose, with no limits.
“Where’s that receipt/ticket/card?”
The Smarter Wallet acts like a personal assistant, helping you find exactly what you need when you need it: event tickets, dry-cleaning tickets, the loyalty card for your favorite café, the right credit card, or a receipt for a return. Everything is neatly labeled and easy to find.
“How can I spend smarter?”
The Smarter Wallet is also a money manager, showing you exactly how much money you have, how much you spend, and how to spend smarter. Tap a credit or debit card to see the balance. Tap a loyalty card to see your rewards balance. Tap again to see at-a-glance spending reports that show you where every dollar went each month. Plus, get exclusive, money-saving offers from your favorite retailers delivered directly to your smartphone.
“Lost Wallet?”
Security expert to the rescue! Unlike an ordinary wallet, the Smarter Wallet is theft-proof, because the contents are locked behind an unbreakable password. If your smartphone goes missing, your financial and personal information remain totally secure, and you can download the contents of your wallet to a new phone without missing a beat.
One hurdle for Lemon might come in the form of the PassBook app Apple just revealed is coming in iOS 6. It is similar enough to Lemon in a few ways. Again, however, Casares is not concerned. He was, in fact, pleased with the news as it "validates the ticketing and couponing compartments of Lemon's Smarter Wallet strategy."
As Lemon can scan credit cards, IDs, and reciepts, ultimately Apple may see this sort of app as a gateway app that gets consumers hooked on digital wallets, before it (possibly) sweeps in with its archive of over 400 million iTunes credit card details and launches a full payments solution of its own.
On Wednesday, the Internet Corporation for Assigned Names and Numbers will release a list of some 2,000 proposals for new Internet address suffixes. They can represent hobbies, ethnic groups, corporate brand names and more.
Expanding the number of suffixes, the ".com" part of an Internet address, has been one of ICANN's missions since its creation in 1998 to oversee domain names. ICANN had two test rounds, in 2000 and 2004, when it added ".info," ".Asia," ".travel," among others. It's now ready to expand the domain name system more broadly.
Here's how it will work:
The applications: The system opened in January. Applicants had to answer 50 questions covering such things as what a proposed suffix will be used for and what kind of financial backing the company or organisation has. They had until late March to begin the application and until May 30 to finish - the deadline was extended because a technical glitch kept the system offline for more than a month. Each application cost $185,000.
The challenges: After ICANN announces on Wednesday the suffixes that have been proposed, the public will have 60 days to comment on them. That is when someone can claim a trademark violation or argue that a proposed suffix is offensive.
The review: ICANN will review each application to make sure its financial plan is sound and that contingencies exist in case a company goes out of business. Applicants also must pass criminal background checks. If multiple applicants seek the same suffix, ICANN will encourage the parties to work out an agreement. The organization will hold an auction if they cannot. The review is expected to take at least nine months, meaning approval of the first batch won't happen until March 2013 or later. If there are challenges or other problems, ICANN believes the review could take up to 20 months.
The launch: Once a suffix gets approved, the applicant will have to set up procedures for registering names under that suffix and computers to keep track of them. Applicants might have all that already completed in anticipation of an approval. The application pays an annual fee that starts at $25,000. The suffix gets activated and becomes available for use. All that could take days or months.
Expanding the number of suffixes, the ".com" part of an Internet address, has been one of ICANN's missions since its creation in 1998 to oversee domain names. ICANN had two test rounds, in 2000 and 2004, when it added ".info," ".Asia," ".travel," among others. It's now ready to expand the domain name system more broadly.
Here's how it will work:
The applications: The system opened in January. Applicants had to answer 50 questions covering such things as what a proposed suffix will be used for and what kind of financial backing the company or organisation has. They had until late March to begin the application and until May 30 to finish - the deadline was extended because a technical glitch kept the system offline for more than a month. Each application cost $185,000.
The challenges: After ICANN announces on Wednesday the suffixes that have been proposed, the public will have 60 days to comment on them. That is when someone can claim a trademark violation or argue that a proposed suffix is offensive.
The review: ICANN will review each application to make sure its financial plan is sound and that contingencies exist in case a company goes out of business. Applicants also must pass criminal background checks. If multiple applicants seek the same suffix, ICANN will encourage the parties to work out an agreement. The organization will hold an auction if they cannot. The review is expected to take at least nine months, meaning approval of the first batch won't happen until March 2013 or later. If there are challenges or other problems, ICANN believes the review could take up to 20 months.
The launch: Once a suffix gets approved, the applicant will have to set up procedures for registering names under that suffix and computers to keep track of them. Applicants might have all that already completed in anticipation of an approval. The application pays an annual fee that starts at $25,000. The suffix gets activated and becomes available for use. All that could take days or months.
Theragenics Corporation |
Below is the Press Release
Theragenics Corporation(R), a medical device company serving the surgical products and prostate cancer treatment markets, today announced it is commencing a modified "Dutch Auction" tender offer to purchase up to $10 million of its common stock. Under the terms of the tender offer, Theragenics stockholders will have the opportunity to tender some or all of their shares at a price within a range of $2.00 to $2.40 per share. Based on the number of shares tendered and the prices specified by the tendering stockholders, Theragenics will determine the lowest per share price within the range that will enable it to buy $10 million of its shares, or such lesser number of shares that are properly tendered. All shares accepted for payment will be purchased at the same price, regardless of whether a stockholder tendered such shares at a lower price within the range. At the minimum price of $2.00 per share, Theragenics would repurchase a maximum of 5,000,000 shares, which represents approximately 14% of Theragenics' currently outstanding common stock. Theragenics will fund this repurchase from available cash on hand. The low and high ends of the price range for the tender offer represent premiums of approximately 14% and 36%, respectively, to the closing price per share of $1.76 for Theragenics' common stock on June 11, 2012, the last trading day prior to the announcement of the tender offer.
Fathers who wait until they’re almost 40 to have children may provide a unique benefit to their offspring: longer lives.
Children of older fathers, those in their late 30s to early 50s, inherit longer telomeres, caps at the end of the chromosomes that protect them from degeneration, according to a study today in the Proceedings of the National Academy of Sciences. Longer telomeres seem to promote slower aging and may mean a longer lifespan for these children, the study said.
Previous research has shown that the older a man is when he reproduces, the more likely the children are to carry spontaneously arising mutations, which can produce disorders like autism. Some research has suggested that children of older fathers also have lower intelligence scores than those born to younger men. Today’s study suggests late fatherhood isn’t all risk, said Dan Eisenberg, a study author and doctoral student at Northwestern University in Evanston, Illinois.
“Most literature also suggests risks from paternal age and this is intriguing, in part, because it stands in contrast to that,” Eisenberg said in a telephone interview. “We don’t really know, on balance, what the net effect is.”
The longer telomeres may delay sexual development, and direct the body’s energy into maintaining itself and staying healthy, he said. The late fatherhood may serve as a signal that mortality rates are low, Eisenberg said. The benefit was also seen in grandchildren of men who became fathers at later ages.
The correlation held regardless of whether the families were rich or poor, the study said.
Damaged Telomeres
Damaged telomeres cause cells to stop dividing, stem cells to become dormant, organs to atrophy and brain cells to die. As most cells age, the telomeres become shorter and shorter. This isn’t the case for sperm, where telomeres lengthen with age. The men may be passing the longer telomeres to their children, boosting their lifespan.
On average, American men have their first child at the age of 25, according to a report from the Centers for Disease Control and Prevention.
Today’s study looked at 2,023 children in the Philippines. There weren’t differences in telomere length between the boys and girls of the same generation, the authors found. The study was funded by the National Science Foundation, the National Institutes of Health, and Northwestern University.
Children of older fathers, those in their late 30s to early 50s, inherit longer telomeres, caps at the end of the chromosomes that protect them from degeneration, according to a study today in the Proceedings of the National Academy of Sciences. Longer telomeres seem to promote slower aging and may mean a longer lifespan for these children, the study said.
Previous research has shown that the older a man is when he reproduces, the more likely the children are to carry spontaneously arising mutations, which can produce disorders like autism. Some research has suggested that children of older fathers also have lower intelligence scores than those born to younger men. Today’s study suggests late fatherhood isn’t all risk, said Dan Eisenberg, a study author and doctoral student at Northwestern University in Evanston, Illinois.
“Most literature also suggests risks from paternal age and this is intriguing, in part, because it stands in contrast to that,” Eisenberg said in a telephone interview. “We don’t really know, on balance, what the net effect is.”
The longer telomeres may delay sexual development, and direct the body’s energy into maintaining itself and staying healthy, he said. The late fatherhood may serve as a signal that mortality rates are low, Eisenberg said. The benefit was also seen in grandchildren of men who became fathers at later ages.
The correlation held regardless of whether the families were rich or poor, the study said.
Damaged Telomeres
Damaged telomeres cause cells to stop dividing, stem cells to become dormant, organs to atrophy and brain cells to die. As most cells age, the telomeres become shorter and shorter. This isn’t the case for sperm, where telomeres lengthen with age. The men may be passing the longer telomeres to their children, boosting their lifespan.
On average, American men have their first child at the age of 25, according to a report from the Centers for Disease Control and Prevention.
Today’s study looked at 2,023 children in the Philippines. There weren’t differences in telomere length between the boys and girls of the same generation, the authors found. The study was funded by the National Science Foundation, the National Institutes of Health, and Northwestern University.
Hindi, one of the foreign languages gaining popularity in China, will be making its debut in South China as Guangdong University of Foreign Studies in Guangzhou is set to open a Hindi chair to teach the language.
A Memorandum of Understanding for establishing a Hindi Chair at the Guangdong University of Foreign Studies (GDUFS), was signed on Monday between the Indian Council for Cultural Relations (ICCR) and the University. This is the first Hindi Chair established by the ICCR in South China.
A number of Chinese universities including the prestigious Peking University, the Beijing Foreign Studies University as well colleges in different parts of China are teaching Hindi.
Lecturers say the language is gaining currency in China as many see it as a career-making proposition in view of rapid increase in India-China trade which touched $ 74 billion last year and is expected to cross $ 100 billion by 2015.
Hindi Day, being organised by the Indian Embassy in Beijing every year, attracts large number of Chinese Hindi enthusiasts from all over China.
Also, Indian expats in Beijing had set up a Sunday school called Gurukul to teach Hindi and Indian culture.
Headed by Lata Iyer, the school has four teachers which included Priya Sunderrajan, Manisha Bhakre, Krishna Dasgupta and Deepa Tulsidas.
The MoU, was signed by Indra Mani Pandey, Consul-General of India in Guangzhou and Zhong Weihe, President of GDUFS, an Indian embassy press release here said.
The ICCR has already established five chairs in China devoted to Hindi and spread of Indian culture including three chairs in Jinan University, Shenzhen University and Yunnan University in various fields of studies.
A Memorandum of Understanding for establishing a Hindi Chair at the Guangdong University of Foreign Studies (GDUFS), was signed on Monday between the Indian Council for Cultural Relations (ICCR) and the University. This is the first Hindi Chair established by the ICCR in South China.
A number of Chinese universities including the prestigious Peking University, the Beijing Foreign Studies University as well colleges in different parts of China are teaching Hindi.
Lecturers say the language is gaining currency in China as many see it as a career-making proposition in view of rapid increase in India-China trade which touched $ 74 billion last year and is expected to cross $ 100 billion by 2015.
Hindi Day, being organised by the Indian Embassy in Beijing every year, attracts large number of Chinese Hindi enthusiasts from all over China.
Also, Indian expats in Beijing had set up a Sunday school called Gurukul to teach Hindi and Indian culture.
Headed by Lata Iyer, the school has four teachers which included Priya Sunderrajan, Manisha Bhakre, Krishna Dasgupta and Deepa Tulsidas.
The MoU, was signed by Indra Mani Pandey, Consul-General of India in Guangzhou and Zhong Weihe, President of GDUFS, an Indian embassy press release here said.
The ICCR has already established five chairs in China devoted to Hindi and spread of Indian culture including three chairs in Jinan University, Shenzhen University and Yunnan University in various fields of studies.
Nupur Mehta |
Mehta's name first surfaced in March this year when a UK daily carried out a sting operation on a Delhi bookie. The sting was done to investigate allegations of match-fixing during the 2011 ICC World Cup held in India, Sri Lanka and Bangladesh. The sting raised suspicions about Mehta being used by bookies to lure players. Although her name was not mentioned by the paper, a blurred image of Mehta was carried along with the story.
"I was quizzed for two-and-a-half hours by the ICC official and they are satisfied with the answers I have provided," Mehta told TOI on Monday. She added that the ICC asked her for names of cricketers who she claims are her social friends, and she provided them.
"I have many friends who are cricketers and with whom I socialize -- Yuvraj (Singh), Parthiv (Patel), Ishant (Sharma). I also know a lot of international players," said Nupur. In the past she has also claimed to have dated Sri Lankan batsman Tillakaratne Dilshan.
When asked about her photograph published in the UK daily, she said she wasn't aware of any bookie nexus and was of the opinion that the daily must have used her photograph to cite her familiarity with international cricketers. "I don't know any bookie and I have no connections with anybody," said Mehta.
The actress, who has only one Bollywood movie (Jo Bole So Nihal) to her credit, said the ICC official kept asking her about how she came to be in touch with the cricketers. "I met them (cricketers) through my event management company and have accompanied them to parties where I kept getting introduced to more players," she said, adding that one player bumped into her in a pub.
"This player was sitting a few feet away and I did not know who he was. After some time he walked up to me to introduce himself. That's how we became friends," Mehta said. She claimed that he then introduced her to other players.
ICC sources, meanwhile, have rubbished Mehta's claims. While they confirm that Peacock did meet Mehta in Mumbai, they said it was for routine questioning. "She's not the only one. From time to time, we have been questioning people -- from cricketers to sponsors. We don't have anything to say on this (Mehta's comments)," said an official in the know of developments.
Pax e-cigarette |
Pax is a $250 electronic cigarette replacement from a young company called Ploom. Small enough to fit in your pocket, Pax heats, never burns your tobacco, releasing a delicious, satisfying vapor. It's the world's most pocketable, premium loose-leaf vaporizer.
Out in August of this year, the Pax accepts any loose leaf tobacco (or recreational herb), and within 30 seconds, transforms it into a puffable, smokeless vapor.
Technology
Vaporization is an alternative method of consuming plant materials instead of smoking. Vaporization is the process of gently heating plant material to release active ingredients that are then inhaled in the form of vapor. A vaporizer extracts the active ingredients of plant materials by using a heating element to heat up plant material (instead of burning it using a flame), resulting in no combustion and eliminating toxic by-products as well as second-hand smoke. As with all portable vaporizers, Ploom utilizes conductional heating, heating the plant material through direct contact. The vapor is delivered via direct inhalation lung delivery
Features
Delivering pure, clean vapor. Since Pax does not heat to combustion there is no smoke nor second hand smoke
compact & magical
Long-lasting permanent internal lithium ion battery. Automatic motion-based temperature control. One beautiful indicator shows status, temperature setting, and charge status with a gentle shake.
refined design
refined design
compact & magical
Long-lasting permanent internal lithium ion battery. Automatic motion-based temperature control. One beautiful indicator shows status, temperature setting, and charge status with a gentle shake.
refined design
refined design
Wide heater chamber for no-effort refill. Industry leading heat-up time. Perfectly silent. Laser-welded stainless steel air path. Multiple colors available
variable heat settings
Adjustable temperature has the most precise control system ever realized in a portable product
easy to use
easy to use
Adjustable temperature has the most precise control system ever realized in a portable product
easy to use
easy to use
Retractable mouthpiece turns the device on and off. Drop it on the included dock to charge
LinkedIn Disables Compromised Passwords, FBI Joins Chase
The FBI has joined the chase to trace the roots of LinkedIn's massive password leak last week. In the meanwhile, director Vicente Silveira has been keeping users updated via the LinkedIn blog. As of Saturday, LinkedIin has disabled any compromised passwords, and informed users, though, as far as LinkedIn is aware, accounts themselves have not been attacked. If your password still works, Silveira explains, LinkedIn doesn't consider your account threatened (but change your password anyway).
ASUS-made Google Tablet May Be Ready For June I/O
Google's new Nexus 7-inch tablet, expected to be manufactured by ASUS, could be ready by the end of June after all--in time for Google's I/O conference. Android Authority has heard from an ASUS employee that the device will cost somewhere between $150 and $250. The tablet will run a quad-core processor made by Nvidia, but opinion is divided over whether the tablet will host Android 4.0 or its newer version, Jellybean. With advanced Google OS specs and at that price, the tablet could challenge both the iPad and e-readers of all stripes.
Twitter Runs First TV Ads With NASCAR
Twitter and racing king NASCAR entered a mutually benefitial new partnership this weekend. A big part of that was a dedicated hashtag page for the event, hosted at twitter.com/#NASCAR, with featured content curated by algorithms and human hands. Also, for the first time, Twitter advertised the page on television ads like this one, showing a driver holding up his iPhone and taking a picture against a tagline that reads "See what he sees."
Lenovo Goes It Alone With Own-Brand Laptop Broadband in EU, U.S.
Lenovo, purveyor of high-end business laptops, has revealed a somewhat unusual move: It's launching its own-branded mobile broadband service in the U.S. and seven European nations, reliant on a single SIM card inside it's compatible laptops and tech from Texas-based Macheen. The service is priced at a cheap entry cost, with no contract, of just $2 for 30 minutes and 30MB, with a capped $9 a day fee and rising to $80 for more data. Targeted at business users who sometimes face exhorbitant Net access fees in hotels or steep data-roaming bills, it's a little more like Amazon's Whispernet than an MVNO. In some ways it's also similar to a plan Steve Jobs had long been rumored to have in his imagination as a way to avoid cell phone network monopolies, and prototype MacBooks with built-in 3G have been seen. With WWDC this week, recent rumors on this matter have swirled around an Apple patent.
The FBI has joined the chase to trace the roots of LinkedIn's massive password leak last week. In the meanwhile, director Vicente Silveira has been keeping users updated via the LinkedIn blog. As of Saturday, LinkedIin has disabled any compromised passwords, and informed users, though, as far as LinkedIn is aware, accounts themselves have not been attacked. If your password still works, Silveira explains, LinkedIn doesn't consider your account threatened (but change your password anyway).
ASUS-made Google Tablet May Be Ready For June I/O
Google's new Nexus 7-inch tablet, expected to be manufactured by ASUS, could be ready by the end of June after all--in time for Google's I/O conference. Android Authority has heard from an ASUS employee that the device will cost somewhere between $150 and $250. The tablet will run a quad-core processor made by Nvidia, but opinion is divided over whether the tablet will host Android 4.0 or its newer version, Jellybean. With advanced Google OS specs and at that price, the tablet could challenge both the iPad and e-readers of all stripes.
Twitter Runs First TV Ads With NASCAR
Twitter and racing king NASCAR entered a mutually benefitial new partnership this weekend. A big part of that was a dedicated hashtag page for the event, hosted at twitter.com/#NASCAR, with featured content curated by algorithms and human hands. Also, for the first time, Twitter advertised the page on television ads like this one, showing a driver holding up his iPhone and taking a picture against a tagline that reads "See what he sees."
Lenovo Goes It Alone With Own-Brand Laptop Broadband in EU, U.S.
Lenovo, purveyor of high-end business laptops, has revealed a somewhat unusual move: It's launching its own-branded mobile broadband service in the U.S. and seven European nations, reliant on a single SIM card inside it's compatible laptops and tech from Texas-based Macheen. The service is priced at a cheap entry cost, with no contract, of just $2 for 30 minutes and 30MB, with a capped $9 a day fee and rising to $80 for more data. Targeted at business users who sometimes face exhorbitant Net access fees in hotels or steep data-roaming bills, it's a little more like Amazon's Whispernet than an MVNO. In some ways it's also similar to a plan Steve Jobs had long been rumored to have in his imagination as a way to avoid cell phone network monopolies, and prototype MacBooks with built-in 3G have been seen. With WWDC this week, recent rumors on this matter have swirled around an Apple patent.
• Sanofi (France) (SAN.PA) Consolidates Data Centers More...
• Roche (RHHBY) CEO Rules Out Additional Big Job Cuts, Eyes Smaller Deals More...
• Cannabis Science Inc. Acquires "Trimcare Brand" and its Full Medical Clinic Operations in Las Vegas Nevada Specializing in Supplements, Skin Care Products, Food, Weight Loss Programs, and Hormone Products More...
• Protalix Biotherapeutics, Inc. (PLX) Gets $25 Million Payment From Pfizer Inc. (PFE) More...
• Zhifei Biological Products Expands Vaccine Partnership With Merck & Co., Inc. (MRK) More...
• Fundacion MEDINA Announces Drug Discovery Collaboration With Cubist Pharmaceuticals, Inc. (CBST) More...
• HUYA Bioscience International Engages In Partnership With Zhuhai Sanzao Science and Technology Industrial Park More...
• Biodel Inc. (BIOD) Obtains Exclusive License to Aegis Therapeutics, LLC' Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations More...
• Knome Appoints Gary A. Cohen as Senior Vice President and General Counsel More...
• Forest Laboratories, Inc. (FRX) Revises Fiscal Year 2013 Earnings Guidance Primarily Due to Evolving Conditions in the Lexapro / escitalopram Market More...
• Johnson & Johnson (JNJ) to Pay $2.2 Billion to End Risperdal Sales Probe More...
• FDA Approves Roche (RHHBY)'s New Breast Cancer Drug More...
• FDA Delays Its Decision on Gilead Sciences, Inc. (GILD)'s Anti-HIV Pill More...
• Sanofi (France) (SAN.PA) Seeks Approval for Diabetes Drug in Japan More...
• AVANIR Pharmaceuticals (AVNR) Announces FDA Acceptance Of IND For AVP-923 For The Treatment Of Agitation In Patients With Alzheimer's Disease More...
• Sanofi (France) (SAN.PA)'s Lantus Cut Blood Sugar More Than Merck & Co., Inc. (MRK)'s Januvia More...
• Novo Nordisk A/S (NVO) Says Victoza Superior to Amylin Pharmaceuticals, Inc. (AMLN) Rival More...
• Johnson & Johnson (JNJ) Diabetes Drug Tops Older Therapies in Studies More...
• GlaxoSmithKline (GSK) Reports Data From Phase III Study of Once-weekly Albiglutide in Type 2 Diabetes More...
• ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Dosing of First Patient in Phase 3 Study of Palifosfamide for the Treatment of Small Cell Lung Cancer More...
• Too Little Sleep Tied to Stroke Risk, University of Alabama at Birmingham Study More...
• Scientists Spot More Migraine Genes, Am van den Maagdenberg of Leiden University Medical Centre Study More...
• Harvard School of Public Health Study Digs Into Secrets of Keeping HIV in Check More...
• Early Menopause Predicts a Milder Form of Rheumatoid Arthritis, Skane University Hospital Study More...
• Physician Therapeutics, Inc. Release: Clinical Trial Shows Theramine® is Safe and Effective for Chronic Back Pain More...
• Mountain View Pharmaceuticals, Inc. Receives European Patent on Potential Long-Acting Drug for Multiple Sclerosis More...
• PIK3CA Gene Patent for Predicting Response to Targeted Therapy Issued - Exclusively Licensed to Transgenomic, Inc. (TBIO) More...
• Roche (RHHBY) CEO Rules Out Additional Big Job Cuts, Eyes Smaller Deals More...
• Cannabis Science Inc. Acquires "Trimcare Brand" and its Full Medical Clinic Operations in Las Vegas Nevada Specializing in Supplements, Skin Care Products, Food, Weight Loss Programs, and Hormone Products More...
• Protalix Biotherapeutics, Inc. (PLX) Gets $25 Million Payment From Pfizer Inc. (PFE) More...
• Zhifei Biological Products Expands Vaccine Partnership With Merck & Co., Inc. (MRK) More...
• Fundacion MEDINA Announces Drug Discovery Collaboration With Cubist Pharmaceuticals, Inc. (CBST) More...
• HUYA Bioscience International Engages In Partnership With Zhuhai Sanzao Science and Technology Industrial Park More...
• Biodel Inc. (BIOD) Obtains Exclusive License to Aegis Therapeutics, LLC' Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations More...
• Knome Appoints Gary A. Cohen as Senior Vice President and General Counsel More...
• Forest Laboratories, Inc. (FRX) Revises Fiscal Year 2013 Earnings Guidance Primarily Due to Evolving Conditions in the Lexapro / escitalopram Market More...
• Johnson & Johnson (JNJ) to Pay $2.2 Billion to End Risperdal Sales Probe More...
• FDA Approves Roche (RHHBY)'s New Breast Cancer Drug More...
• FDA Delays Its Decision on Gilead Sciences, Inc. (GILD)'s Anti-HIV Pill More...
• Sanofi (France) (SAN.PA) Seeks Approval for Diabetes Drug in Japan More...
• AVANIR Pharmaceuticals (AVNR) Announces FDA Acceptance Of IND For AVP-923 For The Treatment Of Agitation In Patients With Alzheimer's Disease More...
• Sanofi (France) (SAN.PA)'s Lantus Cut Blood Sugar More Than Merck & Co., Inc. (MRK)'s Januvia More...
• Novo Nordisk A/S (NVO) Says Victoza Superior to Amylin Pharmaceuticals, Inc. (AMLN) Rival More...
• Johnson & Johnson (JNJ) Diabetes Drug Tops Older Therapies in Studies More...
• GlaxoSmithKline (GSK) Reports Data From Phase III Study of Once-weekly Albiglutide in Type 2 Diabetes More...
• ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Dosing of First Patient in Phase 3 Study of Palifosfamide for the Treatment of Small Cell Lung Cancer More...
• Too Little Sleep Tied to Stroke Risk, University of Alabama at Birmingham Study More...
• Scientists Spot More Migraine Genes, Am van den Maagdenberg of Leiden University Medical Centre Study More...
• Harvard School of Public Health Study Digs Into Secrets of Keeping HIV in Check More...
• Early Menopause Predicts a Milder Form of Rheumatoid Arthritis, Skane University Hospital Study More...
• Physician Therapeutics, Inc. Release: Clinical Trial Shows Theramine® is Safe and Effective for Chronic Back Pain More...
• Mountain View Pharmaceuticals, Inc. Receives European Patent on Potential Long-Acting Drug for Multiple Sclerosis More...
• PIK3CA Gene Patent for Predicting Response to Targeted Therapy Issued - Exclusively Licensed to Transgenomic, Inc. (TBIO) More...